The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
In the latest session, BioCardia Inc. (NASDAQ: BCDA) closed at $0.38 down -2.82% from its previous closing price of $0.39. In other words, the price has decreased by -$2.82 from its previous closing price. On the day, 1.22 million shares were traded. BCDA stock price reached its highest trading level at $0.401 during the session, while it also had its lowest trading level at $0.375.
Ratios:
For a deeper understanding of BioCardia Inc.’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.40 and its Current Ratio is at 0.40.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Apr 19 ’24 when Altman Peter bought 2,750 shares for $0.37 per share. The transaction valued at 1,013 led to the insider holds 558,697 shares of the business.
Altman Peter bought 500 shares of BCDA for $195 on Mar 28 ’24. The President and CEO now owns 555,947 shares after completing the transaction at $0.39 per share. On Feb 13 ’24, another insider, Altman Peter, who serves as the President and CEO of the company, bought 108,108 shares for $0.46 each. As a result, the insider paid 50,000 and bolstered with 555,447 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BCDA now has a Market Capitalization of 10107553 and an Enterprise Value of 10268782. For the stock, the TTM Price-to-Sale (P/S) ratio is 21.06. Its current Enterprise Value per Revenue stands at 21.528 whereas that against EBITDA is -0.888.
Stock Price History:
The Beta on a monthly basis for BCDA is 1.48, which has changed by -0.8164251 over the last 52 weeks, in comparison to a change of 0.23568535 over the same period for the S&P500. Over the past 52 weeks, BCDA has reached a high of $2.92, while it has fallen to a 52-week low of $0.32. The 50-Day Moving Average of the stock is -8.28%, while the 200-Day Moving Average is calculated to be -36.35%.
Shares Statistics:
For the past three months, BCDA has traded an average of 353.13K shares per day and 209490 over the past ten days. A total of 23.67M shares are outstanding, with a floating share count of 17.28M. Insiders hold about 35.70% of the company’s shares, while institutions hold 7.75% stake in the company. Shares short for BCDA as of 1713139200 were 271172 with a Short Ratio of 0.77, compared to 1710460800 on 1013676. Therefore, it implies a Short% of Shares Outstanding of 271172 and a Short% of Float of 1.17.
Earnings Estimates
On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was -$0.17. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between -$0.42 and -$0.71 for the fiscal current year, implying an average EPS of -$0.56. EPS for the following year is -$1.01, with 1.0 analysts recommending between -$1.01 and -$1.01.
Revenue Estimates
Based on 2 analysts’ estimates, the company’s revenue will be $1.88M in the next fiscal year. The high estimate is $3.05M and the low estimate is $700k.
